SHIPHIE PHILIPOSE-SILVA: Open Payments
NPI 1942855895 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,687 in 101 payments from 18 companies in 2025. Trend: 2023 $936 · 2024 $1,404 · 2025 $2,687
Food & beverage: $2,602Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $657 |
| Janssen Biotech, Inc. | 9 | $422 |
| PFIZER INC. | 13 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $227 |
| GENZYME CORPORATION | 4 | $192 |
| Ardelyx, Inc. | 6 | $180 |
| Novo Nordisk Inc | 3 | $155 |
| Phathom Pharmaceuticals, Inc. | 6 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Lilly USA, LLC | 4 | $89 |
Products named: TREMFYA, RINVOQ, VELSIPITY, DUPIXENT, SKYRIZI, IBSRELA, ENTYVIO, Wegovy.
Industry payments across MO — which companies pay providers there.
